Chongqing Zhifei Biological Products Co Ltd
Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China. The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vaccine. It also provides cold storage, refrigerated vehicles, and cold roll boxes; and customs clearance and registration of imported vaccines. The company was founded in 2002 and is based in Chongqing, China.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 300122-SZ would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2010) — listing | $27,008 1.2× | $39,926 1.2× |
| Year 6 (2015) | $11,012 0.7× | $16,298 0.7× |
| Year 11 (2020) | $3,272 0.4× | $4,825 0.4× |
| Year 16 (2025) | $1,393 0.7× | $2,069 0.7× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 300122
For illustration only — not investment advice. Past performance is not indicative of future results.